Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Awakn Life Sciences Corp C.AWKN

Alternate Symbol(s):  AWKNF

Awakn Life Sciences Corp. is a Canada-based clinical-stage biotechnology company. The Company is developing therapeutics for substance use and mental health disorders, with a near-term focus on Alcohol Use Disorder (AUD). The Company's therapeutics are focused on the brain circuits that drive addiction, multiple receptors rather than the traditional single drug receptor targets. The Company... see more

Bullboard (CSE:AWKN)

View:
Post by Jonathon Brownon Dec 19, 2024 6:23am

Buzz on the Bullboards: Three engaging TSX stocks with a holiday flavour

Comment by Badger66on Dec 18, 2024 11:16am

RE:RE:RE:RE:RE:Waiting

I haven't quite been able to iron out how they come to that 20 cents a share number, myself, or for that matter, how the volume of shares traded in Graft Polymer per day exceeds the float of ...more  
Comment by TheBridgeon Dec 17, 2024 11:22pm

RE:RE:RE:RE:Waiting

If I calculated and understood it correctly it turns out to be 20 cents Canadian for each share of AWKN.
Comment by JoeyCCon Dec 17, 2024 1:00pm

RE:RE:RE:Waiting

So my understanding from reading the news articles is that 1 awkn share is 46.67 graft polymer? Is my understanding correct? I am trading on the tax so I wonder what the conversion will be like for a ...more  
Comment by TheBridgeon Dec 17, 2024 10:40am

RE:RE:Waiting

Well it's not the New Year yet but we have a new name prior to the new year arriving. So we're Graft Polymer now, a UK entity and they obviously feel that we were worth taking out. Let's ...more  
Comment by TheBridgeon Dec 16, 2024 4:45pm

RE:Waiting

Looks like we didn't have to wait until the New Year to see the move. Pretty exciting times here!
Post by TheBridgeon Nov 27, 2024 2:55pm

Waiting

Once this tax loss season is over we just might see this share price Awakin and start moving up. But as everyone knows these biotechs are a risky buiness and take a lot of time to determine whether ...more  
Post by Badger66on Sep 26, 2023 9:40am

Stifel - "‘Favourable Commercialization Outcome" PT C$1.75

Analysts at Stifel GMP expect a “favourable commercialization outcome” from Awakn Life Sciences Corp (NEO:AWKN)’s planned Phase 3 trial of novel ketamine drug AWKN-P001 in combination with ...more  
Comment by doggy123on Jun 13, 2023 9:17am

RE:RE:RE:RE:RE:RE:Seem

Unreal why scientists,doctors insiders in this company don't buy at market at this ridiculous price 
Comment by doggy123on Jun 09, 2023 9:24am

RE:RE:RE:RE:RE:Seem

Halted..........
Comment by doggy123on Jun 05, 2023 11:00am

RE:RE:RE:RE:Seem

Q1 should be out pretty soon.......
Comment by doggy123on May 12, 2023 9:18am

RE:RE:RE:Seem

This new company  is a sleeping giant to a world of giant wide problem addictions.......Potential is so high with no interest yet.......watch it it's coming ....$$$
Comment by doggy123on May 04, 2023 9:51am

RE:RE:Seem

Man i would like some comments on this stock.............level 2 is crazy so thin that with some good news this thing could pop up $2.00 plus $3.00 dollars almost instantly.......why some sell now is ...more  
Comment by doggy123on May 01, 2023 7:50pm

RE:Seem

Do your own dd.........Analyst Price target $1.75 buying recommendation rating by Yahoo 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities